ARGX
argenx announces launch of proposed global offering
Monday, July 17, 2023 BiopharmaWatch Research 1 min read Key Takeaway: argenx announces launch of proposed global offering
Price reaction · baseline $379.08 (2023-07-14 close) · 3 other ARGX headline(s) in the window, move may be shared
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+36%
120-day peak, hindsight
Typical move
4.7%
average across 12 past catalysts
Lead asset
Empasiprubart
Phase 2 · AChR-Ab Seropositive Generalized Myasthenia Gravis
Full Press Release Details
argenx announces launch of proposed global offering.